Overview
Infectious disease with peripheral neuropathy is a grouping classification used by Orphanet (ORPHA:206613) to categorize conditions in which peripheral neuropathy occurs as a consequence of an infectious agent. Peripheral neuropathy refers to damage or dysfunction of the peripheral nerves — the nerves outside the brain and spinal cord — leading to symptoms such as numbness, tingling, weakness, and pain, typically in the hands and feet. Several well-known infectious diseases can cause peripheral neuropathy, including leprosy (caused by Mycobacterium leprae), HIV/AIDS, Lyme disease (Borrelia burgdorferi), hepatitis C, diphtheria, and certain viral infections such as varicella-zoster (shingles). The mechanisms by which infections damage peripheral nerves vary and may include direct nerve invasion by the pathogen, immune-mediated nerve damage, or toxin-related injury. The body systems primarily affected include the peripheral nervous system, but depending on the underlying infectious agent, other organ systems such as the skin, liver, musculoskeletal system, and immune system may also be involved. Key clinical features of the peripheral neuropathy component include sensory disturbances (numbness, paresthesias, neuropathic pain), motor weakness, and in some cases autonomic dysfunction (such as abnormal sweating, blood pressure changes, or gastrointestinal symptoms). The severity and pattern of neuropathy depend on the specific infectious etiology. Treatment is directed at the underlying infectious cause and may include antibiotics, antivirals, or antiretroviral therapy, depending on the pathogen involved. Symptomatic management of neuropathic pain with medications such as gabapentin, pregabalin, or tricyclic antidepressants may also be employed. Physical therapy and rehabilitation can help manage motor deficits. Early identification and treatment of the causative infection is critical to preventing irreversible nerve damage.
Variable
Can begin at different ages, from infancy through adulthood
FDA & Trial Timeline
3 eventsCentre Hospitalier Universitaire de Nīmes
CMH Kharian Medical College — NA
Huazhong University of Science and Technology
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Infectious disease with peripheral neuropathy.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Infectious disease with peripheral neuropathy at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Infectious disease with peripheral neuropathy.
Community
No community posts yet. Be the first to share your experience with Infectious disease with peripheral neuropathy.
Start the conversation →Latest news about Infectious disease with peripheral neuropathy
Disease timeline:
New recruiting trial: New Diagnostic Tool (MinION) for Identifying Microorganisms in Foot Wounds of Patients Living With Diabetic Foot Osteomyelitis
A new clinical trial is recruiting patients for Infectious disease with peripheral neuropathy
New recruiting trial: Comparative Efficacy of Pregabalin and Lacosamide in Patients With Herpes Zoster and Post Herpetic Neuralgia
A new clinical trial is recruiting patients for Infectious disease with peripheral neuropathy
New recruiting trial: Risk Factors of Anxiety and Depression in Patients With Herpes Zoster Neuralgia
A new clinical trial is recruiting patients for Infectious disease with peripheral neuropathy
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Infectious disease with peripheral neuropathy
What is Infectious disease with peripheral neuropathy?
Infectious disease with peripheral neuropathy is a grouping classification used by Orphanet (ORPHA:206613) to categorize conditions in which peripheral neuropathy occurs as a consequence of an infectious agent. Peripheral neuropathy refers to damage or dysfunction of the peripheral nerves — the nerves outside the brain and spinal cord — leading to symptoms such as numbness, tingling, weakness, and pain, typically in the hands and feet. Several well-known infectious diseases can cause peripheral neuropathy, including leprosy (caused by Mycobacterium leprae), HIV/AIDS, Lyme disease (Borrelia bur
Which specialists treat Infectious disease with peripheral neuropathy?
18 specialists and care centers treating Infectious disease with peripheral neuropathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.